Medistim ASA
OSE:MEDI

Watchlist Manager
Medistim ASA Logo
Medistim ASA
OSE:MEDI
Watchlist
Price: 160 NOK -1.84% Market Closed
Market Cap: 2.9B NOK
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one MEDI stock under the Base Case scenario is 217.77 NOK. Compared to the current market price of 160 NOK, Medistim ASA is Undervalued by 27%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MEDI Relative Value
Base Case
217.77 NOK
Undervaluation 27%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

5.2
P/S
P/S
Price to Sales
5.2
vs History
90
vs Industry
21
Median 3Y
7.5
Median 5Y
9.5
Industry
2.2
Forward
5.3
More Details
28.2
P/E
P/E
Price to Earnings
28.2
vs History
90
vs Industry
16
Median 3Y
36.4
Median 5Y
44
Industry
21.8
Forward
27.3
More Details
20.5
P/OCF
P/OCF
Price to OCF
20.5
vs History
93
vs Industry
13
Median 3Y
34.6
Median 5Y
36.8
Industry
13.4
More Details
26.8
P/FCFE
P/FCFE
Price to FCFE
26.8
vs History
82
vs Industry
16
Median 3Y
36
Median 5Y
44
Industry
19
More Details
6.7
P/B
P/B
Price to Book Value
6.7
vs History
93
vs Industry
8
Median 3Y
10.3
Median 5Y
12.7
Industry
2.1
More Details
4.9
EV/S
EV/S
Enterprise Value to Sales
4.9
vs History
92
vs Industry
20
Median 3Y
7.2
Median 5Y
9.2
Industry
2.3
Forward
5
More Details
6.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
6.2
vs History
92
vs Industry
29
Median 3Y
9.2
Median 5Y
11.8
Industry
4.8
More Details
17.8
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
17.8
vs History
93
vs Industry
12
Median 3Y
24.5
Median 5Y
33
Industry
11.4
Forward
17.7
More Details
21.2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
21.2
vs History
92
vs Industry
17
Median 3Y
28.3
Median 5Y
34.3
Industry
15.5
Forward
19.7
More Details
19.4
EV/OCF
EV/OCF
Enterprise Value to OCF
19.4
vs History
93
vs Industry
13
Median 3Y
33.5
Median 5Y
35.7
Industry
13.3
More Details
23.4
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
23.4
vs History
84
vs Industry
17
Median 3Y
34.2
Median 5Y
40.1
Industry
17.1
More Details
7
EV/IC
EV/IC
Enterprise Value to IC
7
vs History
93
vs Industry
9
Median 3Y
12.1
Median 5Y
13.8
Industry
1.8
More Details

Multiples Across Competitors

MEDI Competitors Multiples
Medistim ASA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
NO
Medistim ASA
OSE:MEDI
2.9B NOK 5.2 28.2 17.8 21.2
US
Abbott Laboratories
NYSE:ABT
222.5B USD 5.3 16.5 21.4 30.7
US
Intuitive Surgical Inc
NASDAQ:ISRG
183.3B USD 21 74 59 71
US
Boston Scientific Corp
NYSE:BSX
150.1B USD 9 81 37 52.2
US
Stryker Corp
NYSE:SYK
139.2B USD 6.2 46.5 24.1 29.1
IE
Medtronic PLC
NYSE:MDT
107.6B USD 3.2 25.4 13.5 19.1
DE
Siemens Healthineers AG
XETRA:SHL
52.4B EUR 2.3 26.4 15.3 21.8
US
Becton Dickinson and Co
NYSE:BDX
59.5B USD 2.9 34 14.5 26.1
US
Edwards Lifesciences Corp
NYSE:EW
44.5B USD 8.2 10.7 25.1 27.8
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
263.1B CNY 7.1 21.2 18.4 18.4
US
IDEXX Laboratories Inc
NASDAQ:IDXX
35.6B USD 9.1 40.2 28.5 31.8

See Also

Summary
MEDI intrinsic value, competitors valuation, and company profile.
DCF Valuation
MEDI stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MEDI stock valuation using valuation multiples.
Wall Street Estimates
MEDI price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MEDI stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 248,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.